Robert R. Schmidt is a Principal on the U.S. Buyout team at The Carlyle Group, focused on private equity investments in the healthcare sector. He is based in New York.
Since joining Carlyle in 2011, Mr. Schmidt has been involved in a number of the firm’s investments globally, including Beats Electronics, Grand Rounds, MedRisk, One Medical, Ortho Clinical Diagnostics and Sedgwick. He is currently a member of the Board of Directors of Grand Rounds, MedRisk, One Medical and Ortho Clinical Diagnostics.
Prior to joining Carlyle, Mr. Schmidt worked at Welsh, Carson, Anderson & Stowe, a private equity firm focused on information business services and healthcare investments, and Merrill Lynch Global Private Equity, focused on buyouts in North America.
Mr. Schmidt received his M.B.A. from Harvard Business School and a B.S. in economics from The Wharton School at the University of Pennsylvania.